Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide

Published:2019-12-21 Issue:2 Volume:189 Page:269-278
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bankar Aniket¹,Korula Anu¹^ORCID,Kulkarni Uday P.¹,Devasia Anup J.¹,NA Fouzia¹,Lionel Sharon¹,Abraham Aby¹,Balasubramanian Poonkuzhali¹,Janet Nancy Beryl¹,Nair Sukesh C.²,S Sezlian³,Jeyaseelan Visali⁴,N Jeyaseelan⁴,Prasad Jasmine⁵,George Biju¹,Mathews Vikram¹^ORCID

Affiliation:

1. Department of Hematology Christian Medical College Vellore India

2. Department of Immunohematology and Transfusion Medicine Christian Medical College Vellore India

3. Accounts Department Christian Medical College Vellore India

4. Department of Biostatistics Christian Medical College Vellore India

5. Department of Community Medicine Christian Medical College Vellore India

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16343

Reference25 articles.

1. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

2. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

3. Arsenic patent keeps drug for rare cancer out of reach of many

4. Arsenic‐the;Frith J.;Journal of Military and Veterans Health,2013

5. Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term real‐world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all‐trans retinoic acid without chemotherapy—a retrospective, single‐centre study;British Journal of Haematology;2022-12-18

2. Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia;Blood Cancer Journal;2022-01-31

3. Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia;Frontiers in Oncology;2021-02-25

4. Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside;Frontiers in Oncology;2020-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3